New Score for Assessing Bleeding Risk in Patients With Atrial Fibrillation Treated With NOACs

Open Heart - United Kingdom
doi 10.1136/openhrt-2018-000931
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

Assessing the Risk of Bleeding in Patients With Atrial Fibrillation: The Loire Valley Atrial Fibrillation Project

Circulation: Arrhythmia and Electrophysiology
MedicineCardiovascular MedicinePhysiologyCardiology
2012English

The ABC Risk Score for Patients With Atrial Fibrillation – Authors' Reply

The Lancet
Medicine
2016English

Comparison of Bleeding in Patients With Nonvalvular Atrial Fibrillation Treated With Ximelagatran or Warfarin

Archives of Internal Medicine
2006English

Evaluating the HATCH Score for Predicting Progression to Sustained Atrial Fibrillation in ED Patients With New Atrial Fibrillation

American Journal of Emergency Medicine
MedicineEmergency Medicine
2013English

A Risk Score to Predict Future Atrial Fibrillation Derived From Patients With Stroke Initially Presenting With Atrial Fibrillation?

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2010English

Stroke and Bleeding Risk Assessments in Patients With Atrial Fibrillation: Concepts and Controversies

Frontiers in Medicine
Medicine
2020English

Nonsteroidal Anti-Inflammatory Drugs and Bleeding Risk in Anticoagulated Patients With Atrial Fibrillation

Expert Review of Cardiovascular Therapy
Internal MedicineMedicineCardiovascular MedicineCardiology
2015English

Major Bleeding With Dabigatran and Rivaroxaban in Patients With Atrial Fibrillation

Clinical and Applied Thrombosis/Hemostasis
MedicineHematology
2014English

Prevention of Bleeding in Patients With Atrial Fibrillation Undergoing PCI

New England Journal of Medicine
Medicine
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy